GENEVA, Aug. 7 -- LASK PHARMA, INC. filed a patent application (US2026/013724) for “SOLUBLE BONE MORPHOGENETIC PROTEIN (BMP) RECEPTOR TYPE-1B PROTEINS AND USES FOR THE TREATMENT OF RETINOPATHIES”. With publication no. WO/2026/165568, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/71
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....